Cell
Volume 145, Issue 5, 27 May 2011, Pages 692-706
Journal home page for Cell

Article
Recognition of a Mononucleosomal Histone Modification Pattern by BPTF via Multivalent Interactions

https://doi.org/10.1016/j.cell.2011.03.053Get rights and content
Under an Elsevier user license
open archive

Summary

Little is known about how combinations of histone marks are interpreted at the level of nucleosomes. The second PHD finger of human BPTF is known to specifically recognize histone H3 when methylated on lysine 4 (H3K4me2/3). Here, we examine how additional heterotypic modifications influence BPTF binding. Using peptide surrogates, three acetyllysine ligands are indentified for a PHD-adjacent bromodomain in BPTF via systematic screening and biophysical characterization. Although the bromodomain displays limited discrimination among the three possible acetyllysines at the peptide level, marked selectivity is observed for only one of these sites, H4K16ac, in combination with H3K4me3 at the mononucleosome level. In support, these two histone marks constitute a unique trans-histone modification pattern that unambiguously resides within a single nucleosomal unit in human cells, and this module colocalizes with these marks in the genome. Together, our data call attention to nucleosomal patterning of covalent marks in dictating critical chromatin associations.

Highlights

► The BPTF protein recognizes two different histone posttranslational modifications ► Binding both these marks on one nucleosome increases affinity and specificity ► BPTF colocalizes with bivalently marked nucleosomes in the nucleus ► The binding pattern suggests mononucleosomal bivalent marks confer specificity in vivo

Cited by (0)

7

Present address: Department of Molecular Genetics and Cell Biology, The University of Chicago, 920 East 58th Street, Chicago, IL 60637, USA

8

Present address: School of Medicine, Tsinghua University, Beijing 100084, People's Republic of China

9

Present address: MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Headington, Oxford OX3 9DS, UK